You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Suppliers and packagers for generic pharmaceutical drug: POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC


✉ Email this page to a colleague

« Back to Dashboard


POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Am Regent POTASSIUM PHOSPHATES potassium phosphate, dibasic; potassium phosphate, monobasic SOLUTION;INTRAVENOUS 216274 ANDA American Regent, Inc. 0517-2051-25 25 VIAL, SINGLE-DOSE in 1 TRAY (0517-2051-25) / 5 mL in 1 VIAL, SINGLE-DOSE (0517-2051-01) 2023-10-13
Am Regent POTASSIUM PHOSPHATES potassium phosphate, dibasic; potassium phosphate, monobasic SOLUTION;INTRAVENOUS 216274 ANDA American Regent, Inc. 0517-2102-25 25 VIAL, SINGLE-DOSE in 1 TRAY (0517-2102-25) / 15 mL in 1 VIAL, SINGLE-DOSE (0517-2102-01) 2023-10-13
Am Regent POTASSIUM PHOSPHATES potassium phosphate, dibasic; potassium phosphate, monobasic SOLUTION;INTRAVENOUS 216274 ANDA American Regent, Inc. 0517-2505-25 25 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (0517-2505-25) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE (0517-2505-01) 2023-10-13
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drugs: Potassium Phosphate, Dibasic; Potassium Phosphate, Monobasic

Last updated: July 30, 2025


Overview

Potassium phosphate salts, specifically dibasic (K₂HPO₄) and monobasic (KH₂PO₄), serve critical roles across pharmaceuticals, clinical nutrition, and biotechnological applications. Their chemical stability, bioavailability, and compatibility make them essential components for parenteral nutrition, buffer systems, and electrolyte balance therapies.

Identifying reliable suppliers for pharmaceutical-grade potassium phosphate requires understanding the global supply chain, regulatory compliance, and market dynamics. This article examines leading suppliers, emerging manufacturers, sourcing strategies, and compliance considerations to facilitate informed procurement decisions.


Global Market Landscape

The global demand for potassium phosphate salts drives the presence of multiple suppliers spanning North America, Europe, Asia, and emerging markets. The pharmaceutical-grade variants adhere to stringent quality standards such as USP, EP, BP, or Ph. Eur., necessitating suppliers' compliance with Good Manufacturing Practices (GMP) and regulatory approvals from agencies like the FDA, EMA, or equivalent.

Major suppliers are typically established chemical manufacturing firms specializing in inorganic salts, with dedicated divisions for pharmaceutical and reagent-grade chemicals. Market diversification is essential for mitigating supply chain risks due to raw material fluctuations, geopolitical factors, or regulatory shifts.


Leading Suppliers of Pharmaceutical-Grade Potassium Phosphate

1. Thermo Fisher Scientific

Thermo Fisher Scientific offers pharmaceutical-grade potassium phosphate salts, including dibasic and monobasic forms, manufactured under rigorous GMP standards. Their global distribution network ensures consistent supply for biopharmaceutical manufacturing, clinical, and research sectors.

  • Key Features: High purity, strict regulatory compliance, extensive technical support.
  • Certifications: cGMP, ISO 9001, USP, EP.

2. Sigma-Aldrich (Merck Group)

A dominant supplier with a comprehensive portfolio of inorganic chemicals, Sigma-Aldrich supplies both dibasic and monobasic potassium phosphate salts suited for pharmaceutical and laboratory use.

  • Product Attributes: ≥99% purity, traceability, extensive batch documentation.
  • Regulatory: Compliant with USP and EP standards, suitable for injectable and clinical applications when specified.

3. Roquette

Roquette specializes in pharmaceutical and nutraceutical excipients, offering potassium phosphate salts manufactured under high-quality standards for parenteral nutrition.

  • Capabilities: Custom formulations, detailed quality assurance documentation.
  • Certifications: GMP, ISO compliant.

4. Ajinomoto

Ajinomoto Phosphates (Japan-based) supplies pharmaceutical-grade potassium phosphate salts, emphasizing purity, bioavailability, and regulatory compliance, primarily serving the Asian and global markets.

  • Strengths: Long-standing expertise in inorganic phosphates.
  • Certification: cGMP, ISO-certified.

5. Thermo Fisher Scientific’s Local Distributors & Regional Manufacturers

In addition to direct procurement from major multinationals, regional manufacturers in India, China, and Eastern Europe supply potassium phosphate salts following Pharmaceutical Inspection Co-operation Scheme (PIC/S) guidelines, often offering cost-effective options without compromising quality.


Emerging and Niche Suppliers

Several smaller or regional manufacturers are expanding their presence:

  • VWR International – Provides pharmaceutical-grade potassium phosphates suitable for research and small-scale clinical manufacturing.
  • Vitaquest – Offers custom formulations with regulatory documentation and GMP compliance.
  • Major regional producers in India and China – Focused on cost-effective supply, with certifications aligning with global standards.

Supply Chain & Quality Assurance Considerations

  • Regulatory Compliance: Suppliers must comply with cGMP, ISO certifications, and adhere to pharmacopeial standards (USP, EP, BP).
  • Product Specifications: Ensure certificates of analysis (COA), batch traceability, endotoxin levels, sterility testing (for injectable use), and heavy metal limits.
  • Packaging & Storage: Use of pharma-grade containers, tamper-evident seals, and cold chain management where necessary.
  • Supplier Audits & Due Diligence: Critical for assessing manufacturing standards, regulatory track record, and responsiveness.

Sourcing Strategies

  • Direct Procurement: Engage with established suppliers like Sigma-Aldrich, Thermo Fisher, or Roquette directly for guaranteed compliance and supply consistency.
  • Distribution Partnerships: Work with authorized distributors to access regional or specialized products with added logistical support.
  • Bulk Purchasing & Long-term Contracts: Reduce unit costs, secure priority supply, and establish reliable vendor relationships.
  • Local Manufacturing Agreements: For large-scale or ongoing requirements, consider partnerships with regional manufacturers adhering to global standards for cost efficiencies.

Regulatory & Compliance Challenges

  • Quality Certification: Selecting suppliers with validated manufacturing processes aligned with pharmacopeial standards prevents regulatory issues.
  • Traceability & Documentation: Critical for audits, recalls, and regulatory submissions.
  • Import Regulations: Navigating customs, tariffs, and import licenses in various jurisdictions.

Conclusion

Securing pharmaceutical-grade potassium phosphate salts necessitates a strategic approach centered on quality, compliance, and supply stability. Major global suppliers like Thermo Fisher Scientific, Sigma-Aldrich, Roquette, and Ajinomoto remain primary sources, supported by regional manufacturers offering competitive options. Diligent supplier vetting, adherence to regulatory standards, and meticulous quality assurance underpin effective procurement, minimizing risks and ensuring drug safety.


Key Takeaways

  • The primary suppliers of pharmaceutical-grade potassium phosphate salts include Thermo Fisher Scientific, Sigma-Aldrich, Roquette, and Ajinomoto, all recognized for rigorous quality standards.
  • Regional manufacturers from India, China, and Eastern Europe offer cost-efficient alternatives, provided they meet international regulatory certifications.
  • Ensuring supplier compliance with pharmacopeial standards and GMP practices is crucial for regulatory approval and product safety.
  • Sourcing strategies should incorporate direct contracts, distributor partnerships, and long-term agreements to maintain supply continuity.
  • Regulatory diligence, thorough product documentation, and quality assurance processes are essential for mitigating supply chain risks.

FAQs

Q1. What are the key regulatory standards to consider when sourcing potassium phosphate salts?
Answer: The essential standards include USP, EP, BP, or Ph. Eur., along with GMP compliance, endotoxin limits, and sterility requirements for injectable formulations.

Q2. How does supplier certification impact pharmaceutical-quality potassium phosphate?
Answer: Certifications such as ISO and GMP ensure manufacturing consistency, traceability, and regulatory compliance, critical for pharmaceutical applications.

Q3. Are regional chemical manufacturers reliable sources for pharmaceutical potassium phosphate?
Answer: They can be, provided they meet international standards, have proper certifications, and maintain rigorous quality controls. Due diligence and audits are recommended.

Q4. What are the primary applications of potassium phosphate salts in pharmaceuticals?
Answer: They are used in parenteral nutrition, buffer systems, electrolyte repletion therapies, and in biotechnological processes.

Q5. How can supply chain risks associated with potassium phosphate sourcing be mitigated?
Answer: Through diversified supplier relationships, long-term procurement contracts, quality audits, and maintaining buffer stock levels.


Sources
[1] Sigma-Aldrich Product Information.
[2] Thermo Fisher Scientific Pharmaceutical Chemicals Catalogue.
[3] Roquette Corporation - Pharmaceutical Ingredients.
[4] Ajinomoto Group Product Data.
[5] WHO Guidelines on Pharmaceutical Quality Assurance.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.